Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA
A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo VIEW POSTER PDF
Article Date
April 8, 2024
This article is featured on another website.
Go to article
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
April 20, 2026
Meet HiRO at COG New England Conference on April 28-29!
HiRO to Attend COG New England Conference, April 28–29 Clinical development is becoming increasingly global,…
April 20, 2026
Meet HiRO at COG New England Conference on April 28-29!
HiRO to Attend COG New England Conference, April 28–29 Clinical development is becoming increasingly global,…